Skip to main navigation Skip to search Skip to main content

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

  • J. Compston
  • , D.M. Reid
  • , J. Boisdron
  • , M.L. Brandi
  • , N. Burlet
  • , D. Cahall
  • , P.D. Delmas
  • , W. Dere
  • , J.P. Devogelaer
  • , L.A. Fitzpatrick
  • , B. Flamion
  • , N. Goel
  • , S. Korte
  • , A. Laslop
  • , B. Mitlak
  • , S. Ormarsdottir
  • , J. Ringe
  • , R. Rizzoli
  • , Y. Tsouderos
  • , T.P. van Staa
  • J.Y. Reginster
  • extern

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1247-1250
Number of pages4
JournalOsteoporosis International
Volume19
Publication statusPublished - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Epidemiology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Ziekenhuisstructuur en organisatie van de gezondheidszorg
  • Public Health

Cite this